taraxasterol has been researched along with concanavalin a in 2 studies
Studies (taraxasterol) | Trials (taraxasterol) | Recent Studies (post-2010) (taraxasterol) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
---|---|---|---|---|---|
56 | 0 | 44 | 17,959 | 82 | 1,337 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ge, B; Sang, R; Wang, Z; Xu, L; Yu, Y; Zhang, X | 1 |
Chen, MY; He, XH; Hu, B; Huang, YT; Liu, SY; Ouyang, DY; Shi, FL; Shi, ZJ; Xu, LH; Xu, R; Ye, XJ; Zeng, B; Zha, QB | 1 |
2 other study(ies) available for taraxasterol and concanavalin a
Article | Year |
---|---|
Taraxasterol from
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; bcl-2-Associated X Protein; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Cytoprotection; Glutathione; Hepatocytes; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sterols; Superoxide Dismutase; Taraxacum; Toll-Like Receptors; Transcription Factor RelA; Triterpenes; Tumor Necrosis Factor-alpha | 2019 |
Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes.
Topics: Animals; Anti-Inflammatory Agents; Cell Proliferation; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Female; Interleukin-2; Liver; Mice, Inbred C57BL; Signal Transduction; Sterols; T-Lymphocytes; Triterpenes | 2022 |